Lawmakers have ghost networks in their sights, and payers can prepare now for policy changes. The post Navigating Policy Terrain: Perspectives for Payers on Tackling Ghost Networks appeared first on MedCity News.

Hospitals’ operating margins and patient volumes dropped slightly in March. While hospitals were doing relatively well financially during the first quarter of the year, this new data could suggest more financial challenges ahead for hospitals. But right now, it’s unclear whether the recent declines in hospitals’ margins and volumes will be short- or...

Offering blended options, individual risk pools, and net neutral capitation payments providers can embark on their journey toward value-based care at a pace aligned with their tolerance and readiness. The post Navigating the Transition to Value-Based Care: Addressing Fears and Embracing Risk in ACO REACH appeared first on MedCity News.

Amgen is confident its injectable obesity drug would have a differentiated profile compared to medications now on the market from Novo Nordisk and Eli Lilly and it’s now preparing for Phase 3 testing. But an oral obesity drug in Amgen’s pipeline will not advance beyond Phase 1. The post Amgen Puts Its Weight Behind Obesity Drug With Potential Edge...

Andrew Witty, CEO of UnitedHealth Group, faced bipartisan outrage from senators on the Senate Finance Committee angered by his company’s cybersecurity failures. Here were the key moments from the hearing on Wednesday. The post Key Moments From the Change Healthcare Cyberattack Senate Hearing appeared first on MedCity News.

Kaiser Permanente is deploying Innovaccer’s healthcare AI platform and population health management tools to support better value-based care — starting with its Washington market and potentially expanding to new markets in the future. The post Kaiser Permanente Is Deploying Innovaccer’s Value-Based Care AI Across Washington appeared first on MedCity...